NVCT: Nuvectis Pharma Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Nuvectis Pharma Inc (NVCT).
$104.53M Market Cap.
NVCT Market Cap. (MRY)
NVCT Shares Outstanding (MRY)
NVCT Assets (MRY)
Total Assets
$18.61M
Total Liabilities
$8.89M
Total Investments
$0
NVCT Income (MRY)
Revenue
$0
Net Income
-$19.00M
Operating Expense
$19.85M
NVCT Cash Flow (MRY)
CF Operations
-$12.25M
CF Investing
$0
CF Financing
$11.65M
NVCT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $18,607,000 (-3.01%) | $19,185,000 (-5.98%) | $20,405,000 (206.52%) | $6,657,000 (0%) |
Assets Current | $18,607,000 (-3.01%) | $19,185,000 (-5.98%) | $20,405,000 (249.82%) | $5,833,000 (0%) |
Assets Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $824,000 (0%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $9,713,000 (-20.39%) | $12,201,000 (-14.19%) | $14,219,000 (229.17%) | -$11,008,000 (-109980.00%) |
Property Plant & Equipment Net | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $18,533,000 (-3.10%) | $19,126,000 (-4.34%) | $19,993,000 (248.19%) | $5,742,000 (0%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,498,000 (-9.85%) | $2,771,000 (-4.78%) | $2,910,000 (175.05%) | $1,058,000 (10480.00%) |
Accumulated Retained Earnings (Deficit) | -$73,245,000 (-35.03%) | -$54,245,000 (-69.60%) | -$31,985,000 (-147.95%) | -$12,900,000 (-128900.00%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $8,894,000 (27.35%) | $6,984,000 (12.90%) | $6,186,000 (155.73%) | $2,419,000 (24090.00%) |
Liabilities Current | $8,894,000 (27.35%) | $6,984,000 (12.90%) | $6,186,000 (155.73%) | $2,419,000 (24090.00%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
NVCT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $6,929,000 (-7.82%) | $7,517,000 (25.14%) | $6,007,000 (79.37%) | $3,349,000 (33390.00%) |
Research & Development Expense | $12,918,000 (-16.01%) | $15,380,000 (16.28%) | $13,227,000 (38.58%) | $9,545,000 (0%) |
Operating Expenses | $19,847,000 (-13.32%) | $22,897,000 (19.04%) | $19,234,000 (49.17%) | $12,894,000 (128840.00%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$19,000,000 (14.65%) | -$22,260,000 (-16.64%) | -$19,085,000 (-48.06%) | -$12,890,000 (-128800.00%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$19,000,000 (14.65%) | -$22,260,000 (-16.64%) | -$19,085,000 (-48.06%) | -$12,890,000 (-128800.00%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$19,000,000 (14.65%) | -$22,260,000 (-16.64%) | -$19,085,000 (-48.06%) | -$12,890,000 (-128800.00%) |
Weighted Average Shares | $17,113,169 (10.01%) | $15,556,655 (22.90%) | $12,657,651 (196.55%) | $4,268,285 (4168.28%) |
Weighted Average Shares Diluted | $17,113,169 (10.01%) | $15,556,655 (22.90%) | $12,657,651 (196.55%) | $4,268,285 (4168.28%) |
Earning Before Interest & Taxes (EBIT) | -$19,000,000 (14.65%) | -$22,260,000 (-16.64%) | -$19,085,000 (-48.06%) | -$12,890,000 (-128800.00%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$19,847,000 (13.32%) | -$22,897,000 (-19.04%) | -$19,234,000 (-49.17%) | -$12,894,000 (-128840.00%) |
NVCT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $11,654,000 (-22.75%) | $15,087,000 (-45.75%) | $27,810,000 (82.41%) | $15,246,000 (0%) |
Net Cash Flow from Operations | -$12,247,000 (23.24%) | -$15,954,000 (-17.66%) | -$13,559,000 (-42.67%) | -$9,504,000 (0%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$593,000 (31.60%) | -$867,000 (-106.08%) | $14,251,000 (148.19%) | $5,742,000 (0%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $11,654,000 (127.84%) | $5,115,000 (-83.95%) | $31,879,000 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
NVCT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -160.80% (-11.05%) | -144.80% (-15.01%) | -125.90% (-153.80%) | 234.00% |
Return on Average Assets (ROAA) | -102.80% (4.64%) | -107.80% (-8.89%) | -99.00% (74.44%) | -387.30% |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 292.00% (-35.20%) | 450.60% (-21.81%) | 576.30% (-66.16%) | 1702.80% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -4.87 (16.43%) | -5.83 (-17.41%) | -4.97 | - |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 10.76 (-9.14%) | 11.84 (53.36%) | 7.72 | - |
Debt to Equity Ratio (D/E) | 0.92 (60.14%) | 0.57 (31.49%) | 0.43 (297.73%) | -0.22 (78.00%) |
Earnings Per Share (EPS) | -1.11 (22.38%) | -1.43 (5.30%) | -1.51 (50.00%) | -3.02 (-2920.00%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.72 (30.21%) | -1.03 (4.20%) | -1.07 (51.91%) | -2.23 (0%) |
Book Value Per Share (BVPS) | 0.57 (-27.55%) | 0.78 (-30.19%) | 1.12 (143.54%) | -2.58 (-2479.00%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.09 (-11.84%) | 1.23 (-23.51%) | 1.61 (3.33%) | 1.56 (0%) |
Enterprise Value Over EBIT (EV/EBIT) | -5 (16.67%) | -6 (-20.00%) | -5 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.6 (16.42%) | -5.5 (-21.81%) | -4.52 | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 |
Current Ratio | 2.09 (-23.84%) | 2.75 (-16.73%) | 3.3 (36.83%) | 2.41 (0%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$12,247,000 (23.24%) | -$15,954,000 (-17.66%) | -$13,559,000 (-42.67%) | -$9,504,000 (0%) |
Enterprise Value (EV) | $87,357,464 (-28.66%) | $122,444,794 (42.08%) | $86,178,622 | - |
Earnings Before Tax (EBT) | -$19,000,000 (14.65%) | -$22,260,000 (-16.64%) | -$19,085,000 (-48.06%) | -$12,890,000 (-128800.00%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$19,000,000 (14.65%) | -$22,260,000 (-16.64%) | -$19,085,000 (-48.06%) | -$12,890,000 (-128800.00%) |
Invested Capital | -$8,820,000 (-27.36%) | -$6,925,000 (-19.93%) | -$5,774,000 (-283.91%) | -$1,504,000 (-14940.00%) |
Working Capital | $9,713,000 (-20.39%) | $12,201,000 (-14.19%) | $14,219,000 (316.49%) | $3,414,000 (34240.00%) |
Tangible Asset Value | $18,607,000 (-3.01%) | $19,185,000 (-5.98%) | $20,405,000 (206.52%) | $6,657,000 (0%) |
Market Capitalization | $104,526,464 (-27.67%) | $144,503,794 (31.58%) | $109,818,622 | - |
Average Equity | $11,813,500 (-23.16%) | $15,373,250 (1.39%) | $15,163,000 (375.24%) | -$5,509,000 |
Average Assets | $18,481,500 (-10.50%) | $20,649,000 (7.09%) | $19,281,750 (479.29%) | $3,328,500 |
Invested Capital Average | -$6,507,000 (-31.72%) | -$4,940,000 (-49.18%) | -$3,311,500 (-337.45%) | -$757,000 |
Shares | 19,320,973 (11.51%) | 17,326,594 (18.33%) | 14,642,483 (26.22%) | 11,601,127 (0.00%) |
